Cargando…
(64)Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
[Image: see text] Prostate-specific membrane antigen (PSMA) is a well-recognized target for identification and therapy of a variety of cancers. Here we report five (64)Cu-labeled inhibitors of PSMA, [(64)Cu]3–7, which are based on the lysine–glutamate urea scaffold and utilize a variety of macrocycl...
Autores principales: | Banerjee, Sangeeta Ray, Pullambhatla, Mrudula, Foss, Catherine A., Nimmagadda, Sridhar, Ferdani, Riccardo, Anderson, Carolyn J., Mease, Ronnie C., Pomper, Martin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983358/ https://www.ncbi.nlm.nih.gov/pubmed/24533799 http://dx.doi.org/10.1021/jm401921j |
Ejemplares similares
-
A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2011) -
[(64)Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
por: Minn, Il, et al.
Publicado: (2016) -
A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts
por: Azad, Babak Behnam, et al.
Publicado: (2016) -
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
por: Shen, Colette J., et al.
Publicado: (2020) -
Imaging of carbonic anhydrase IX with an (111)In-labeled dual-motif inhibitor
por: Yang, Xing, et al.
Publicado: (2015)